10-Q: Kewaunee Scientific Corporation Reports Mixed Results in Q1 2025, Gross Margin Improves Despite Sales Dip

Kewaunee Scientific Corporation's first quarter of fiscal year 2025 saw a slight decrease in sales but an increase in gross profit margin, alongside a decrease in net earnings compared to the same period last year.

Summary

• Kewaunee Scientific Corporation reported net sales of $48.393 million for the quarter ended July 31, 2024, a decrease from $49.839 million in the same period last year.
• Domestic sales were relatively flat at $35.523 million, while international sales decreased by 10.7% to $12.870 million due to customer construction site delays in India.
• The company's order backlog increased to $159.4 million as of July 31, 2024, compared to $140.8 million last year and $155.6 million at the end of the previous quarter.
• Gross profit margin improved to 25.8% of sales, up from 23.9% in the prior year, primarily due to a favorable sales mix in domestic operations.
• Operating expenses increased to $9.913 million, or 20.5% of sales, compared to $8.106 million, or 16.3% of sales, in the prior year, driven by higher SG&A costs, consulting fees, and international operating expenses.
• Net earnings attributable to Kewaunee Scientific Corporation were $2.193 million, or $0.74 per diluted share, compared to $2.474 million, or $0.86 per diluted share, in the same quarter last year.
• The company's effective tax rate was 7.9% for the quarter, compared to 26.3% in the prior year, due to the impact of foreign operations and a discrete tax benefit of $421,000.
• The company had working capital of $56.012 million at July 31, 2024, with a current ratio of 2.5-to-1.0.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to decreased sales and earnings, offset by improved gross margins and a strong backlog. The international delays are a concern, but the company's overall financial health appears stable.

Positives

• The gross profit margin increased to 25.8%, driven by a favorable sales mix in domestic operations.
• The company's order backlog increased to $159.4 million, indicating strong future demand.
• The company's working capital remains strong at $56.012 million with a current ratio of 2.5-to-1.0.
• The effective tax rate was favorably impacted by a discrete tax benefit of $421,000.

Negatives

• Net sales decreased to $48.393 million, down from $49.839 million in the same quarter last year.
• International sales decreased by 10.7% due to construction delays in India.
• Operating expenses increased to $9.913 million, or 20.5% of sales, due to higher SG&A costs, consulting fees, and international operating expenses.
• Net earnings decreased to $2.193 million, or $0.74 per diluted share, compared to $2.474 million, or $0.86 per diluted share, in the prior year period.

Risks

• The company's ability to predict future demand is limited due to its role as a subcontractor or supplier.
• Demand is dependent on the number of laboratory construction projects and their progress.
• Earnings are impacted by fluctuations in pricing and raw material costs, including steel, wood, and epoxy resin.
• International operations are subject to risks including foreign currency fluctuations and construction delays.

Future Outlook

The company continues to focus on supporting its dealers and distribution channel partners domestically while continuing to provide turnkey solutions in the international markets it serves. The company believes it is well-positioned due to a strong global management team, a healthy backlog, improved manufacturing capabilities, and end-use markets that continue to prioritize investment in projects that require the products Kewaunee designs and manufactures.

Management Comments

• The increase in gross profit margin percentage for the three months ended July 31, 2024 is primarily being generated from Domestic operations.
• The increase is primarily driven by a favorable sales mix when compared to the prior year, which included installation services sold directly to end users that were completed at a loss for the Company.
• The Company continues to focus on supporting its dealers and distribution channel partners domestically while continuing to provide turnkey solutions in the international markets it serves.

Industry Context

The company operates in the laboratory furniture and equipment industry, which is influenced by the level of investment in research and development and the construction of new laboratory facilities. The company's performance is tied to the overall health of the construction industry and the demand for scientific infrastructure.

Comparison to Industry Standards

• Kewaunee's gross profit margin of 25.8% is within the range of other companies in the specialty furniture and laboratory equipment sector, but specific comparisons are difficult without detailed competitor data.
• Companies like Hamilton Scientific and Thermo Fisher Scientific, which also operate in the lab equipment space, typically have higher revenue but may have different margin profiles due to their broader product offerings.
• Kewaunee's backlog of $159.4 million suggests a healthy demand for its products, which is a positive indicator compared to industry averages, but the impact of construction delays in India highlights the risks of international projects.
• The company's current ratio of 2.5-to-1.0 indicates a strong liquidity position, which is generally considered healthy for companies in this sector.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net earnings and sales.
• Employees may be impacted by changes in operating expenses and potential future adjustments.
• Customers may experience delays in international projects due to construction site issues.
• Suppliers may be affected by changes in demand and production schedules.

Next Steps

• The company will continue to focus on supporting its dealers and distribution channel partners domestically.
• The company will continue to provide turnkey solutions in the international markets it serves.
• The company will monitor the impact of construction delays in India on future sales.

Key Dates

Keywords

laboratory furniture, scientific equipment, fume hoods, laboratory construction, international sales, gross profit margin, order backlog, financial results, Kewaunee Scientific